scholarly journals Superficially serrated adenoma: Novel precursor in the serrated pathway

2021 ◽  
Author(s):  
Kazutomo Togashi

Praxis ◽  
2002 ◽  
Vol 91 (39) ◽  
pp. 1589-1593
Author(s):  
Reinacher-Schick ◽  
Schmiegel

Die Identifizierung der Adenom-Karzinom-Sequenz mit ihren korrespondierenden molekulargenetischen Veränderungen hat entscheidend zum Verständnis der Pathogenese des kolorektalen Karzinoms (KRK) beigetragen. Aufgrund des häufigen biallelischen Verlustes, bzw. der Inaktivierung bestimmter Tumorsuppressorgene (APC, p53 u.a.) wird dieser Karzinogeneseweg üblicherweise «suppressor pathway» genannt. Hierfür charakteristisch ist eine genetische Instabilität auf chromosomaler Ebene. Nicht alle genetischen Veränderungen, die in der Kolonkarzinogenese eine Rolle spielen, lassen sich jedoch in dieses lineare Tumorprogressionsmodell einordnen. So entwickelt sich ein Teil der hereditären und sporadischen KRK auf dem Boden einer genetischen Instabilität auf DNA-Ebene (nachgewiesen als sog. Mikrosatelliteninstabilität, MSI). Dieser Weg der Kolonkarzinogenese wird auch «mutator pathway» genannt. Während sich die Familiäre Adenomatöse Polyposis (FAP) dem «suppressor pathway» zuordnen lässt, folgen die hereditären nicht-polypösen kolorektalen Karzinome (HNPCC) typischerweise dem «mutator pathway». Obwohl sich wahrscheinlich die meisten MSI-Karzinome ebenfalls aus kolorektalen Adenomen entwickeln, gibt es erste Hinweise, dass ein Teil der MSI-Tumoren möglicherweise aus bestimmten hyperplastischen Polypen über sog. «serrated adenoma» entsteht (sog. «serrated pathway»). In dieser Übersicht sollen die unterschiedlichen Wege der Kolonkarzinomentstehung dargestellt werden. Neben den molekularen Veränderungen sollen die morphologischen und klinischen Korrelate, die diese Karzinogenesewege kennzeichnen, aufgezeigt werden. Abschliessend werden praxisrelevante Aspekte des Themas diskutiert.



2014 ◽  
Vol 27 (10) ◽  
pp. 1375-1385 ◽  
Author(s):  
Jia-Huei Tsai ◽  
Jau-Yu Liau ◽  
Yu-Lin Lin ◽  
Liang-In Lin ◽  
Yi-Chen Cheng ◽  
...  


2018 ◽  
Vol 12 (1) ◽  
pp. 116-124 ◽  
Author(s):  
Makoto Eizuka ◽  
Keisuke Kawasaki ◽  
Yosuke Toya ◽  
Risaburo Akasaka ◽  
Koki Otsuka ◽  
...  

In a 64-year-old woman, we identified a flat, elevated lesion that was located at the caecum and was composed of 3 different areas (areas A, B, and C). We diagnosed it as “carcinoma with sessile serrated adenoma/polyp (SSA/P)” histologically. Although area A was diagnosed as classical SSA/P, area B was regarded as a high-grade SSA/P. In contrast, area C showed a differentiated-type adenocarcinoma that invaded the submucosa. The patient had a recurrence of cancer 1.5 years after endoscopic resection. Overexpression of TP53 was detected in area C. Although BRAF mutation was detected in all areas, CpG island methylator phenotype-high cancer was found only in area C. The genomic phenotype of the cancerous tissue was classified as microsatellite stable (MLH1 gene not methylated). In the present case, we showed that a lesion with genetic alterations based on the histological sequence SSA/P → high-grade SSA/P → cancer in SSA/P and an alternative serrated pathway may exhibit aggressive behavior.



2021 ◽  
Author(s):  
Misaki Hidaka ◽  
Moriya Iwaizumi ◽  
Terumi Taniguchi ◽  
Satoshi Baba ◽  
Satoshi Osawa ◽  
...  

Abstract Background The serrated pathway is a distinct genetic/epigenetic mechanism of the adenoma-carcinoma sequence in colorectal carcinogenesis. Although many groups have reported the genetic-phenotypic correlation of serrated lesions (SLs), previous studies regarding the serrated pathway were conducted on patients with SLs that have heterogeneous germline genetic backgrounds. We aimed to compare pure somatic genetic profiles among SLs within identical patients with SPS as a homogenous germline background. Methods We analysed SLs from one patient with SPS (Case #1) and compared DNA variant profiles using targeted DNA multigene panels via NGS among the patient’s hyperplastic polyp (HP), three sessile serrated lesions (SSLs), and one traditional serrated adenoma (TSA), in addition to leucocytes as a germline variant, and separately analysed three SSLs and one tubular adenoma (TA) within another patient with SPS (Case #2). Results In two patients, no germline pathogenic variant was observed, and a known pathogenic variant of BRAF (c.1799T > A, p.Val600Glu) was observed in one TSA and one SSL in Case #1, while three SSLs exhibited the BRAF variant in Case #2. Further, the genetic profile of TA is consistent with the adenoma-carcinoma sequence pathway profile and distinct from that of the other SLs within the same patient with SPS. Conclusions These findings of pure somatic genetic variant profiles among SLs with identical germline genetic background support the previous results analysed among SLs with heterogeneous germline genetic backgrounds.



2015 ◽  
Vol 2015 ◽  
pp. 1-7 ◽  
Author(s):  
Łukasz Szylberg ◽  
Marlena Janiczek ◽  
Aneta Popiel ◽  
Andrzej Marszałek

Colorectal cancer (CRC) is the third most frequently diagnosed cancer in the world. For a long time, only one pathway of colorectal carcinogenesis was known. In recent years, a new “alternative” pathway through serrated adenoma was described. Recent meta-analysis estimated these cancers as about 10% to 30% of all CRCs. Serrated polyps are the second most popular groups of polyps (after conventional adenomas) found during colonoscopy. Serrated polyps of the colon are clinically and molecularly diverse changes that have common feature as crypt luminal morphology characterized by glandular serration. Evidence suggests that subtypes of serrated polyps, particularly TSA and SSA/P, can lead to adenocarcinoma through the serrated pathway. Moreover, the data indicate that the SSA/P are the precursors of colorectal carcinoma by MSI and may be subject to rapid progression to malignancy. An important step to reduce the incidence of CRC initiated by the serrated pathway is to improve the detection of serrated polyps and to ensure their complete removal during endoscopy. Understanding of the so-called serrated carcinogenesis pathway is an important step forward in expanding possibilities in the prevention of CRC.



2016 ◽  
Vol 40 (10) ◽  
pp. 1352-1359 ◽  
Author(s):  
Jia-Huei Tsai ◽  
Jau-Yu Liau ◽  
Chang-Tsu Yuan ◽  
Yu-Lin Lin ◽  
Li-Hui Tseng ◽  
...  




2019 ◽  
Author(s):  
N Ageykina ◽  
N Oleynikova ◽  
P Malkov ◽  
E Fedorov ◽  
N Danilova ◽  
...  




Sign in / Sign up

Export Citation Format

Share Document